• Home
  • Editorial Board
  • Articles
    • Editorials
    • Guest Articles
  • News
    • Featured
    • Biotech News
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues – Archives
  • Subscribe
  • Contact
Facebook Twitter Instagram
Trending
  • CDC Boss kicked out in RFK Jr.’s War on Corruption in pharma and healthcare
  • Prof. Rajeev Varshney FRS, now joins Australian Academy of Science
  • Dr. Cyrus S. Poonawalla, SII unveiled the newly built School for Hearing Impaired in Pune
  • AdFalciVax: ICMR’s New Malaria Vaccine: Hope or Premature Hype?”
  • The Sudden Deaths and COVID Vaccines: A Critical Analysis of the ICMR and AIIMS Studies
  • KGMU Scandal: Dr. Tulika Chandra Exposed in Crore Rupee Forgery and Scam
  • Zydus to launch market-specific dosage variants of Semaglutide, MD says
  • Biocon Biologics Launches Nepexto, Etanercept Biosimilar in Australia
Thursday, October 2
Facebook Twitter Instagram LinkedIn
Biotech Express
  • Home
  • Editorial Board
  • Articles
    • Editorials
    • Guest Articles
  • News
    • Featured
    • Biotech News
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    04/01/20241

    Interview: Reach to common man is the heart and soul of India International Science Festival- Dr. Arvind C Ranade Chief Coordinator, IISF- 2023

    Recent
    04/01/2024

    Interview: Reach to common man is the heart and soul of India International Science Festival- Dr. Arvind C Ranade Chief Coordinator, IISF- 2023

    22/05/2023

    Prof Rajeev Varshney becomes the 4th Indian Agricultural Scientist to be elected as Fellow of the Royal Society

    26/07/2022

    We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

  • Issues – Archives
  • Subscribe
  • Contact
Biotech Express
You are at:Home»Articles»Editorial: Detrimental consequences of not approving eligible and safe COVID-19 vaccine on world’s health: the case of COVAXIN

Editorial: Detrimental consequences of not approving eligible and safe COVID-19 vaccine on world’s health: the case of COVAXIN

0
By Biotech Express on 19/08/2021 Articles, Editorials, SARS- CoV2 & COVID-19 Updates

by Seema Pavgi Upadhye

Keeping away the desperate from the needed resources in emergency is equivalent to crime which is under commitment when the organizations like USFDA and WHO are not approving a vaccine because it is Made in India. Politicization of COVID is not new since the beginning of pandemic but here the points have been discussed to understand what it cost to ignore COVAXIN when whole world is suffering from this catastrophe.

Rise of Variants- All viruses like every living thing evolve over time, due to the replication errors, some mutations are beneficial but some can be dangerous too. Pathogens if develop a mutation that can affect host then it is a matter of concern for health professionals. In SARS- CoV 2 too it has been seen that delayed eradication has given rise to variants which appeared in different countries. This is due to the fact that the virus has been stuck between politics. At many instances delaying vaccination by any means gave virus chances to replicate and thus become more dangerous.

Travel Prohibition- Non approval of Indian vaccine has lessen the chance of foreign visit by Indians in other countries. This has hampered community to much extent, for example the students are not able to go back to their foreign institutions, businessman are not able to meet supply chain people etc. This has greatly shrunk international economic activities which in some cases is applicable to life saving commodities like food and medicines.

Quarantine Cost-  Because Indian vaccine are not allowed outside India, vaccinee have to quarantine themselves for 14-28 days depending on the country. Again this step has greatly increased the budget of international travelers.

Unavailability to Poor Countries – Since the whole world is struggling to get rid of CoV-2, many countries specially the wealthy ones, have stockpiled vaccines in advance. Since this vaccine business is highly capital intensive, only wealthy nations could afford to buy it and thus the poor/poorer nations are not able to get it which again is posing danger because these unvaccinated people would again make the transmission chain possible.

Doubt Over Credibility of Health Agencies’ – It has also been seen that drugs have been approved based on the country of origin and have given special privileges. EUA approval by FDA and WHO of several drugs in lack of evidence is a proof of this. Now, COVAXIN which is available after rigorous studies and clinical trials have been seeking for approval and this has been delayed because of political turmoil.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

CDC Boss kicked out in RFK Jr.’s War on Corruption in pharma and healthcare

Prof. Rajeev Varshney FRS, now joins Australian Academy of Science

Dr. Cyrus S. Poonawalla, SII unveiled the newly built School for Hearing Impaired in Pune

Leave A Reply Cancel Reply

Current Issue – September 2025
Biotech Express – e-ISSN: 2454-6968

Editorial Board

For Authors – Article Submission and Guidelines

Peer Review Policies

License and Copyright

Advertisement

Recent Posts
  • CDC Boss kicked out in RFK Jr.’s War on Corruption in pharma and healthcare 21/09/2025
  • Prof. Rajeev Varshney FRS, now joins Australian Academy of Science 20/09/2025
  • Dr. Cyrus S. Poonawalla, SII unveiled the newly built School for Hearing Impaired in Pune 19/09/2025
  • AdFalciVax: ICMR’s New Malaria Vaccine: Hope or Premature Hype?” 18/09/2025
  • The Sudden Deaths and COVID Vaccines: A Critical Analysis of the ICMR and AIIMS Studies 17/09/2025
  • KGMU Scandal: Dr. Tulika Chandra Exposed in Crore Rupee Forgery and Scam 16/09/2025
  • Zydus to launch market-specific dosage variants of Semaglutide, MD says 15/09/2025
  • Biocon Biologics Launches Nepexto, Etanercept Biosimilar in Australia 15/09/2025
  • India launched its first National Biofoundry Network 15/09/2025
  • India has 94 Biotech Incubators across 25 states over 13 years 15/09/2025
Archives
Categories
  • Articles
  • Biotech News
  • Controversial
  • Editorials
  • Events
  • Featured
  • Guest Articles
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • News-Industry
  • News-Research
  • Policies
  • SARS- CoV2 & COVID-19 Updates
  • Start-ups
About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Submission Policy and Guidelines

Submission policies

 

 

Follow us on Social Media
  • Facebook
  • Twitter
  • YouTube
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2025 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.